1. Home
  2. FRSX vs INDP Comparison

FRSX vs INDP Comparison

Compare FRSX & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSX
  • INDP
  • Stock Information
  • Founded
  • FRSX N/A
  • INDP 2000
  • Country
  • FRSX Israel
  • INDP United States
  • Employees
  • FRSX N/A
  • INDP N/A
  • Industry
  • FRSX Computer Software: Prepackaged Software
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRSX Technology
  • INDP Health Care
  • Exchange
  • FRSX Nasdaq
  • INDP Nasdaq
  • Market Cap
  • FRSX 7.1M
  • INDP 6.0M
  • IPO Year
  • FRSX 2017
  • INDP N/A
  • Fundamental
  • Price
  • FRSX $2.23
  • INDP $3.62
  • Analyst Decision
  • FRSX
  • INDP Strong Buy
  • Analyst Count
  • FRSX 0
  • INDP 2
  • Target Price
  • FRSX N/A
  • INDP $238.00
  • AVG Volume (30 Days)
  • FRSX 72.5K
  • INDP 1.4M
  • Earning Date
  • FRSX 09-21-2025
  • INDP 11-11-2025
  • Dividend Yield
  • FRSX N/A
  • INDP N/A
  • EPS Growth
  • FRSX N/A
  • INDP N/A
  • EPS
  • FRSX N/A
  • INDP N/A
  • Revenue
  • FRSX $452,000.00
  • INDP N/A
  • Revenue This Year
  • FRSX N/A
  • INDP N/A
  • Revenue Next Year
  • FRSX N/A
  • INDP N/A
  • P/E Ratio
  • FRSX N/A
  • INDP N/A
  • Revenue Growth
  • FRSX N/A
  • INDP N/A
  • 52 Week Low
  • FRSX $1.98
  • INDP $2.22
  • 52 Week High
  • FRSX $18.41
  • INDP $58.24
  • Technical
  • Relative Strength Index (RSI)
  • FRSX 64.94
  • INDP 45.47
  • Support Level
  • FRSX $2.06
  • INDP $2.86
  • Resistance Level
  • FRSX $2.30
  • INDP $4.50
  • Average True Range (ATR)
  • FRSX 0.12
  • INDP 0.99
  • MACD
  • FRSX -0.06
  • INDP 0.25
  • Stochastic Oscillator
  • FRSX 55.01
  • INDP 19.01

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: